Inspiration Healthcare Group PLC Renewal of Tecotherm and Micrel Agreements

TIDMIHC

Inspiration Healthcare Group PLC

03 July 2018

3 July 2018

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Renewal of Tecotherm and Micrel Agreements

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, is pleased to announce that it has renewed its long term distribution contract with TecCom GmbH ("TecCom"). TecCom manufactures a range of the highly successful Tecotherm Neo product which is used to cool and warm babies in neonatal intensive care settings. The Company also announces that it has agreed the renewal of its long term contract with Micrel Medical Devices SA ("Micrel"), the manufacturers of a range of infusion pumps.

Inspiration Healthcare has been the exclusive distributor of Tecotherm products on a worldwide basis for over 11 years and has, through supporting clinical research, helped establish the range as market leader in many countries around the world. The range of products include the Techotherm Neo designed for the cooling and warming of babies particularly in the treatment of Neonatal Encephalopathy that may cause cerebral palsy in a newborn.

An earlier version of the Tecotherm Neo, the Tecotherm TSmed200 was used in the TOBY study in the UK, which researched whole body hypothermia for the treatment of perinatal asphyxial encephalopathy and demonstrated the benefits of cooling in this patient cohort.

Inspiration Healthcare has been the distributor of Micrel products in the UK and Ireland for a number of years. The products are used in a wide range of infusion therapies including parenteral feeding, post operative pain management, regional analgesia, chemotherapy and a range of other applications. Micrel currently has a number of new products under development and the directors believe that Inspiration is well positioned to explore the potential of these once they are released.

Commenting today, Neil Campbell Inspiration Healthcare's Chief Executive Officer said: " We have worked successfully with both these companies for many years and are delighted to have been able to extend the relationship for future years. Both companies have outstanding products which have proven many times that they will improve the medical outcomes for patients and this is the fundamental criteria for Inspiration Healthcare selecting partners with which we can work"

Enquiries:

 
 Inspiration Healthcare Group      Tel: [phone] 
  plc 
  Neil Campbell, Chief Executive 
  Officer 
  Mike Briant, Chief Financial 
  Officer 
 Nominated Adviser & Broker        Tel: [phone] 
  Cenkos Securities plc 
  Mark Connelly 
                                  ------------------- 
 Cadogan PR                        Tel: [phone] 
  Alex Walters 
                                  ------------------- 
 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NRARTMBTMBJMTLP

(END) Dow Jones Newswires

July 03, 2018 02:00 ET (06:00 GMT)